The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion

Diabetes

Volumn 51, Issue SUPPL. 3, 2002, Pages

  MacDonald, Patrick E ^a   El kholy, Wasim ^a   Riedel, Michael J ^a   Salapatek, Anne Marie F ^a   Light, Peter E ^b   Wheeler, Michael B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CATION CHANNEL; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; POTASSIUM CHANNEL;

CONFERENCE PAPER; ENERGY METABOLISM; EXOCYTOSIS; GLUCAGON RELEASE; HORMONE ACTION; HORMONE RELEASE; INSULIN RELEASE; INTESTINE MOTILITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SATIETY; STOMACH ACID SECRETION; WEIGHT REDUCTION;

EID: 0036894315     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.2007.s434     Document Type: Conference Paper

References (106)

1. Drucker DJ: Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 122:531-544, 2002
2. Fehmann HC, Goke R, Goke B: Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev 16:390-410, 1995
3. Drucker DJ: Minireview: The glucagon-like peptides. Endocrinology 142: 521-527, 2001
4. Perfetti R, Merkel P: Glucagon-like peptide-1: A major regulator of pancreatic β-cell function. Eur J Endocrinol 143:717-725, 2000
5. Edvell A, Lindstrom P: Initiation of increased pancreatic islet growth in young normoglycemic mice (Umea +/?). Endocrinology 140:778-783, 1999
6. Buteau J, Roduit R, Susini S, Prentki M: Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duotenal homeobox gene 1 (PDX-1) DNA binding activity in β(INS-1)-cells. Diabetologia 42:856-864, 1999
7. Stoffers DA, Kieffer TJ, Hussain MA, Drucker DJ, Bonner-Weir S, Habener JF, Egan JM: Insulinotropic glucagon-like peptide 1 agonists stimulated expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 49:741-748, 2000
8. Perfetti R, Zhou J, Doyle ME, Egan JM: Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology 141:4600-4605, 2000.
9. Wang X, Zhou J, Doyle ME, Egan JM: Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic β-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism. Endocrinology 142: 1820-1827, 2001
10. Buteau J, Foisy S, Rhodes CJ, Carpenter L, Biden TJ, Prentki M: Protein kinase C activation mediates glucagon-like peptide-1-induced pancreatic β-cell proliferation. Diabetes 50:2237-2243, 2001
11. Hui H, Wright C, Perfetti R: Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-l-positive pancreatic ductal cells into insulin-secreting cells. Diabetes 50:785-796, 2001
12. Xu G, Stoffers DA, Habener JF, Bonner-Weir S: Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48:2270-2276, 1999
13. Tourrel C, Bailbe D, Meile MJ, Kergoat M, Portha B: Glucagon-like peptide-1 and exendin-4 stimulate β-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes 50:1562-1570, 2001
14. Pederson RA, Satkunarajah M, McIntosh CH, Scrocchi LA, Flamez D, Schuit F, Drucker DJ, Wheeler MB: Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice. Diabetes 47:1046-1052, 1998
15. Ling Z, Wu D, Zambre Y, Flamez D, Drucker DJ, Pipeleers DG, Schuit FC: Glucagon-like peptide 1 receptor signaling influences topography of islet cells in mice. Virchows Arch 438:382-387, 2001
16. Giralt M, Vergara P: Glucagonlike peptide-1 (GLP-1) participation in ileal brake induced by intraluminal peptones in rat. Dig Dis Sci 44:322-329, 1999
17. Tolessa T, Gutniak M, Holst JJ, Efendic S, Hellstrom PM: Inhibitory effect of glucagon-like peptide-1 on small bowel motility: Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. J Clin Invest 102:764-774, 1998
18. Holst JJ: Gut hormones as pharmaceuticals: From enteroglucagon to GLP-1 and GLP-2. Regul Pept 93:45-51, 2000
19. Gutzwiller JP, Drewe J, Goke B, Schmidt H, Rohrer B, Lareida J, Beglinger C: Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol 276: R1541-R1544, 1999
20. van Dijk G, Thiele TE: Glucagon-like peptide-1 (7-36) amide: A central regulator of satiety and interoceptive stress. Neuropeptides 33:406-414, 1999
21. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR: A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69-72, 1996
22. Meeran K, O'Shea D, Edwards CM, Turton MD, Heath MM, Gunn I, Abusnana S, Rossi M, Small CJ, Goldstone AP, Taylor GM, Sunter D, Steere J, Choi SJ, Ghatei MA, Bloom SR: Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology 140:244-250, 1999
23. Szayna M, Doyle ME, Betkey JA, Holloway HW, Spencer RG, Greig NH, Egan JM: Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats. Endocrinology 141:1936-1941, 2000
24. Scrocchi LA, Brown TJ, MaClusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ: Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2:1254-1258, 1996
25. Toft-Nielsen MB, Madsbad S, Holst JJ: Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. Diabetes Care 22:1137-1143, 1999
26. Saltiel AR, Kahn CR: Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806, 2001
27. Raptis SA, Dimitriadis GD: Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers. Exp Clin Endocrinol Diabetes 109 (Suppl. 2):S265-S287, 2001
28. Turner RC: The U.K. Prospective Diabetes Study: A review. Diabetes Care 21 (Suppl. 3):C35-C38, 1998
29. Pederson RA, White HA, Schlenzig D, Pauly RP, McIntosh CH, Demuth HU: Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes 47:1253-1258, 1998
30. Pospisilik JA, Stafford SG, Demuth HU, Brownsey R, Parkhouse W, Finegood DT, McIntosh CH, Pederson RA: Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and β-cell glucose responsiveness in VDF (fa/fa) Zucker rats. Diabetes 51:943-950, 2002
31. Sudre B, Broqua P, White RB, Ashworth D, Evans DM, Haigh R, Junien JL, Aubert ML: Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male Zucker diabetic fatty rats. Diabetes 51:1461-1469, 2002
32. Deacon CF, Hughes TE, Holst JJ: Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig. Diabetes 47:764-769, 1998
33. De Meester I, Korom S, Van Damme J, Scharpe S: CD26, let it cut or cut it down. Immunol Today 20:367-375, 1999
34. Aizawa T, Komatsu M, Asanuma N, Sato Y, Sharp GW: Glucose action 'beyond ionic events' in the pancreatic β-cell. Trends Pharmacol Sci 19:496-499, 1998
35. ATP channel-independent signaling pathways in human islets. Diabetes 47:758-763, 1998
36. Ronner P, Naumann CM, Friel E: Effects of glucose and amino acids on free ADP in βHC9 insulin-secreting cells. Diabetes 50:291-300, 2001
37. + channels: Generating excitement in pancreatic β-cells. Diabetes 45:845-853, 1996
38. Gromada J, Ding WG, Barg S, Renstrom E, Rorsman P: Multisite regulation of insulin secretion by cAMP-increasing agonists: Evidence that glucagon-like peptide 1 and glucagon act via distinct receptors. Pflugers Arch 434:515-524, 1997
39. Lin YF, Jan YN, Jan LY: Regulation of ATP-sensitive potassium channel function by protein kinase A-mediated phosphorylation in transfected HEK293 cells. EMBO J 19:942-955, 2000
40. Leech CA, Holz GG, Habener JF: Signal transduction of PACAP and GLP-1 in pancreatic β-cells. Ann N Y Acad Sci 805:81-92, 1996
41. Holz GG, Kuhtreiber WM, Habener JF: Pancreatic β-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 361:362-365, 1993
42. Suga S, Kanno T, Ogawa Y, Takeo T, Kamimura N, Wakui M: cAMPindependent decrease of ATP-sensitive K+ channel activity by GLP-1 in rat pancreatic β-cells. Pflugers Arch 440:566-572, 2000
43. Ashcroft FM, Rorsman P: Electrophysiology of the pancreatic β-cell. Prog Biophys Mol Biol 54:87-143, 1989
44. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H: Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265:5267-5272, 1990
45. Light PE, Manning-Fox JE, Riedel MJ, Wheeler MB: Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A and ADP-dependent mechanism Mol Endocrinol 16:2135-2144, 2002
46. + channel in mouse pancreatic β-cells. Exp Physiol 86:331-339, 2001
47. Kieffer TJ, Habener JF: The glucagon-like peptides. Endocr Rev 20:876-913, 1999
48. ATP channel: Separate roles of Kir6.2 and SUR1 subunit phosphorylation. EMBO J 18:4722-4732, 1999
49. Nichols CG, Shyng SL, Nestorowicz A, Glaser B, Clement JP, Gonzalez G, Aguilar-Bryan L, Permutt MA, Bryan J: Adenosine diphosphate as an intracellular regulator of insulin secretion. Science 272:1785-1787, 1996
50. +ATP current in intact mouse pancreatic β-cells. Biochem Biophys Res Commun 207:33-39, 1995
51. 2+ current through L-type Ca2+ channel of rat pancreatic beta-cells in a cAMP-dependent manner. Diabetes 46:1755-1760, 1997
52. Gromada J, Bokvist K, Ding WG, Holst JJ, Nielsen JH, Rorsman P: Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic β-cells by both proximal and distal regulatory steps in stimulus-secretion coupling. Diabetes 47:57-65, 1998
53. 2+-dependent insulin secretion from the islets of Langerhans. Endocrine 13:251-262, 2000
54. 2+ channels. Mol Endocrinol 16:884-895, 2002
55. Melliti K, Meza U, Adams B: Muscarinic stimulation of alpha1E Ca channels is selectively blocked by the effector antagonist function of RGS2 and phospholipase C-β1. J Neurosci 20:7167-7173, 2000
56. Salapatek AMF, MacDonald PE, Gaisano HY, Wheeler MB: Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells. Mol Endocrinol 13:1305-1317, 1999
57. Tsien RW, Bean BP, Hess P, Lansman JB, Nilius B, Nowycky MC: Mechanisms of calcium channel modulation by beta-adrenergic agents and dihydropyridine calcium agonists. J Mol Cell Cardiol 18:691-710, 1986
58. Tiaho F, Richard S, Lory P, Nerbonne JM, Nargeot J: Cyclic-AMP-dependent phosphorylation modulates the stereospecific activation of cardiac Ca channels by Bay K 8644. Pflugers Arch 417:58-66, 1990
59. Fraser ID, Tavalin SJ, Lester LB, Langeberg LK, Westphal AM, Dean RA, Marrion NV, Scott JD: A novel lipid-anchored A-kinase anchoring protein facilitates cAMP-responsive membrane events. EMBO J 17:2261-2272, 1998
60. Gromada J, Dissing S, Bokvist K, Renstrom E, Frokjaer-Jensen J, Wulff BS, Rorsman P: Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting β TC3-cells by enhancement of intracellular calcium mobilization. Diabetes 44:767-774, 1995
61. 2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37). J Biol Chem 274:14147-14156, 1999
62. 2+ and electrolyte mobilization following agonist application to the pancreatic β-cell line HIT. Pflugers Arch 440:828-834, 2000
63. Bootman MD, Berridge MJ: The elemental principles of calcium signaling. Cell 83:675-678, 1995
64. Berridge MJ: Microdomains and elemental events in calcium signalling. Cell Calcium 20:95-96, 1996
65. Berridge MJ: Elementary and global aspects of calcium signalling. J Physiol 499 (Pt. 2):291-306, 1997
66. Islam MS, Leibiger I, Leibiger B, Rossi D, Sorrentino V, Ekstrom TJ, Westerblad H, Andrade FH, Berggren PO: In situ activation of the type 2 ryanodine receptor in pancreatic β-cells requires cAMP-dependent phosphorylation. Proc Natl Acad Sci U S A 95:6145-6150, 1998
67. Kashima Y, Miki T, Shibasaki T, Ozaki N, Miyazaki M, Yano H, Seino S: Critical role of cAMP-GEFII-Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem 276:46046-46053, 2001
68. 2+ release in INS-1 pancreatic β-cells. J Physiol 536:375-385, 2001
69. Bode HP, Moormann B, Dabew R, Goke B: Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic β-cells independently of protein kinase A. Endocrinology 140:3919-3927, 1999
70. Wheeler MB, Lu M, Dillon JS, Leng XH, Chen C, Boyd AE III: Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C. Endocrinology 133:57-62, 1993
71. Zawalich WS, Zawalich KC, Rasmussen H: Influence of glucagon-like peptide-1 on β-cell responsiveness. Regul Pept 44:277-283, 1993
72. Zawalich WS, Zawalich KC: Glucagon-like peptide-1 stimulates insulin secretion but not phosphoinositide hydrolysis from islets desensitized by prior exposure to high glucose or the muscarinic agonist carbachol. Metabolism 45:273-278, 1996
73. + channel families regulate insulin secretion. Mol Endocrinol 15:1423-1435, 2001
74. + channels in the insulin-secreting cell line INS-1. Pflugers Arch 442:49-56, 2001
75. Walsh KB, Begerdsich TB, Kass RS: Beta-adrenergic modulation of cardiac ion channels: Differential temperature sensitivity of potassium and calcium currents. J Gen Physiol 93:841-854, 1989
76. Choquet D, Sarthou P, Primi D, Cazenave PA, Korn H: Cyclic AMP-modulated potassium channels in murine B cells and their precursors. Science 235:1211-1214, 1987
77. Walsh KB, Kass RS: Regulation of a heart potassium channel by protein kinase A and C. Science 242:67-69, 1988
78. Chung S, Kaczmarek LK: Modulation of the inactivation of voltagedependent potassium channels by cAMP. J Neurosci 15:3927-3935, 1995
79. Duchatelle-Gourdon I, Hartzell HC: Single delayed rectifier channels in frog atrial cells: Effects of beta-adrenergic stimulation. Biophys J 57:903-909, 1990
80. + channels in the squid giant axon. I. Steady-state conditions. J Gen Physiol 98:1-17, 1991
81. Huang XY, Morielli AD, Peralta EG: Molecular basis of cardiac potassium channel stimulation by protein kinase A. Proc Natl Acad Sci U S A 91:624-628, 1994
82. + channel alpha subunit modulates the inactivation conferred by a beta subunit: Involvement of cytoskeleton. J Biol Chem 271:29321-29328, 1996
83. Kwak YG, Hu NN, Wei J, George AL, Grobaski TD, Tamkun MM, Murray KT: Protein kinase A phosphorylation alters Kvβ1.3 subunit-mediated inactivation of the Kv1.5 potassium channel. J Biol Chem 274:13928-13932, 1999
84. Potet F, Scott JD, Mohammad-Panah R, Escande D, Baro I: AKAP proteins anchor cAMP-dependent protein kinase to KvLQT 1/IsK channel complex. Am J Physiol Heart Circ Physiol 280:H2038-H2045, 2001
85. 2+i surges: Aberrant behavior in ob/ob mice. Am J Physiol 264:C1458-C1465, 1993
86. Drake PF, Treistman SN: Mechanisms of action of cyclic nucleotides on a bursting pacemaker and silent neuron in aplysia. Brain Res 218:243-254, 1981
87. Costa MR, Casnellie JE, Catterall WA: Selective phosphorylation of the alpha subunit of the sodium channel by cAMP-dependent protein kinase. J Biol Chem 257:7918-7921, 1982
88. Connor JA, Hockberger P: A novel membrane sodium current induced by injection of cyclic nucleotides into gastropod neurones. J Physiol 354: 139-162, 1984
89. Qian F, Huang P, Ma L, Kuznetsov A, Tamarina N, Philipson LH: TRP genes: Candidates for nonselective cation channels and store-operated channels in insulin-secreting cells. Diabetes 51 (Suppl. 1): S183-S189, 2002
90. Satoh J, Kutsuwada K, Ohki G, Imai M, Kobayashi M, Suzuki M: Cyclic AMP stimulates the gene expression of a non-selective cation channel, mNSC1, in pancreatic β-cell line, MIN6. Mol Cell Endocrinol 160:165-171, 2000
91. 2+-signaling pathway in pancreatic β-cells by the insulinotropic hormone glucagon-like peptide-1. J Biol Chem 270:17749-17757, 1995
92. 2+-sensitive nonselective cation channels in regulating the membrane potential of pancreatic β-cells. Diabetes 47:1066-1073, 1998
93. Straub SG, Kornreich B, Oswald RE, Nemeth EF, Sharp GW: The calcimimetic R-467 potentiates insulin secretion in pancreatic β-cells by activation of a nonspecific cation channel. J Biol Chem 275:18777-18784, 2000
94. + channel current that is activated by cell swelling, cAMP, and glyburide in insulin-secreting cells. Diabetes 44:1461-1466, 1995
95. Hryciw DH, Guggino WB: Cystic fibrosis transmembrane conductance regulator and the outwardly rectifying chloride channel: A relationship between two chloride channels expressed in epithelial cells. Clin Exp Pharmacol Physiol 27:892-895, 2000
96. 2+ mobilization. FEBS Lett 425: 277-280, 1998
97. ATP channel-deficient mice. Proc Natl Acad Sci U S A 95:10402-10406, 1998
98. ATP channel-independent regulation of insulin secretion. J Biol Chem 275:9270-9277, 2000
99. 2+-dependent exocytosis in pancreatic β-cells. Diabetes 51 (Suppl. 1):S19-S24, 2002
100. Wollheim CB, Maechler P: β-cell mitochondria and insulin secretion: Messenger role of nucleotides and metabolites. Diabetes 51 (Suppl. 1):S37-S42, 2002
101. Gromada J, Holst JJ, Rorsman P: Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1. Pflugers Arch 435:583-594, 1998
102. Ammala C, Ashcroft FM, Rorsman P: Calcium-independent potentiation of insulin release by cyclic AMP in single β-cells. Nature. 363:356-358, 1993
103. Renstrom E, Eliasson L, Rorsman P: Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic β-cells. J Physiol 502 (Pt. 1):105-118, 1997
104. 2+-induced exocytosis in mouse pancreatic β-cells. J Physiol 503 (Pt. 2):399-412, 1997
105. Wheeler MB, Sheu L, Ghai M, Bouquillon A, Grondin G, Weller U, Beaudoin AR, Bennett MK, Trimble WS, Gaisano HY: Characterization of SNARE protein expression in β-cell lines and pancreatic islets. Endocrinology 137:1340-1348, 1996
106. Yaney GC, Civelek VN, Richard AM, Dillon JS, Deeney JT, Hamilton JA, Korchak HM, Tornheim K, Corkey BE, Boyd AE 3rd: Glucagon-like peptide 1 stimulates lipolysis in clonal pancreatic β-cells (HIT). Diabetes 50:56-62, 2001